Egalet Reports Second Quarter 2018 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. ANT
3. SPY
4. FFAI
5. FFR
6. CART
7. LLY
8. TSLA
9. META
10. FICO

Go back to Egalet Reports Second Quarter 2018 Financial Results

Egalet (EGLT) Tops Q2 EPS by 6c, Revenues Miss

August 8, 2018 6:19 AM EDT

Egalet (NASDAQ: EGLT) reported Q2 EPS of ($0.22), $0.06 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $7.4 million versus the consensus estimate of $7.99 million.

"In the second quarter, we continued to grow our commercial products and improve our payer coverage," said Bob Radie, president and chief executive officer of Egalet. "Since the beginning of the year, we have had five commercial market access wins which we believe should improve patient access to both SPRIX Nasal Spray and ARYMO ER."

Cash Position: As of June 30, 2018, Egalet had cash, marketable securities... More